Man Group PLC Harvard Bioscience Inc Transaction History

Man Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$4.19 - $6.16 $13,604 - $20,001	-3,247 Reduced 15.48%	17,728 $97,000
Q1 2023 May 15, 2023	SELL	$2.45 - $4.22 $48,987 - $84,378	-19,995 Reduced 48.8%	20,975 $88,000
Q4 2022 Feb 14, 2023	BUY	$2.12 - $2.86 $35,259 - $47,567	16,632 Added 68.34%	40,970 $113,000
Q3 2022 Nov 14, 2022	BUY	$2.33 - $3.92 $29,083 - $48,929	12,482 Added 105.28%	24,338 $62,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.42 $38,887 - $76,115	11,856 New	11,856 $43,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.